Connect with Boston Scientific at NANS

Orlando, FL 
January 13-15
Follow us on LinkedIn and use #NANS2022 to join the conversation.

Events: Saturday, January 15


Boston Scientific Pain Management Solutions: Pursuing Advancement Together

12-1:30pm ET
Southern Hemisphere 2
Walt Disney World Dolphin Resort

Featured Faculty: Anjum Bux, MD, Michael Esposito, MD, Dr. Dragan Gastevski, MD, FASA, Jennifer Lee, MD, Pankaj Mehta, MD, Louis Raso, MD
Moderator: Henry Vucetic, MD 

Lunch will be served

Register Now

Clinical and Scientific Presentations


Spinal Cord Stimulation


  

Oral Presentations

  • COMBO RCT: Two-Year Outcomes of an SCS System Capable of Simultaneous Delivery of Multiple Modalities 
    Saturday, January 15 from 4:25-4:35pm ET
    Presented by: Mark Wallace, MD 

  • Patient States: Artificial Intelligence-Driven Metrics Providing Comprehensive Yet Straightforward Understanding of Chronic Pain Patients
    Friday, January 14 from 11:35-11:45am ET
    Presented by: Magdalena Anitescu, MD, PhD
  • Identifying Alternative Cells Involved in SCS Therapy
    Friday, January 14 from 4:00-5:00pm ET
    Presented by: Professor Warren M. Grill, PhD, Duke University, and Magdalena Anitescu, MD, PhD

  • Prospective, Multicenter Evaluation of Novel Fast-Acting Sub-Perception-Based Spinal Cord Stimulation for Chronic Pain: FAST Study
    Saturday, January 15 from 4:15-4:25pm ET
    Presented by: Magdalena Anitescu, MD, PhD

Paper Posters

  • Artificial Intelligence-Driven Closed-Loop SCS:  Early Patient Feedback on Personalized Therapy Recommendations from a Digital Health Assistant
    Rauck et al.  
  • Capturing the Chronic Pain Patient Experience Using a Novel Digital Ecosystem
    Thomson et al.  
  • Clinical Outcomes Using SCS-Based Combination Therapy: A European, Multicenter Study in Patients with Chronic Pain
    Kallewaard et al. 
  • Comprehensive Digital Tools to Improve Access to Care and Treatment Efficiency for Spinal Cord Stimulation
    Vucetic et al.  
  • Enhanced Efficiency and Clinical Outcomes Using Fast Acting Sub-perception Therapy (FAST)
    North et al.  
  • Modeling and Measurement of the Effect of Low-Amplitude Spinal Cord Stimulation (SCS) on Dorsal Column (DC) Axons and Wide Dynamic Range (WDR) Neurons
    Titus et al. 
  • Improved Outcomes and Pain Relief Using Novel Fast-Acting Sub-Perception SCS
    Ferro et al.  
  • Long-Term Chronic Pain-Relief Outcomes Using an SCS System Capable of Combination Therapy
    Metzger et al.  
  • Outcomes of Previously-Implanted SCS Chronic Pain Patients Converted to New SCS System — European Experience
    Rigoard et al.  
  • Pain Relief Outcomes Using Neuromodulation Systems with Multiple Waveform and Programming Modalities: An Australian Case-Series
    Georgius et al.  
  • Pain Relief Outcomes Using Peripheral Nerve Field Stimulation (PNFS) combined with Spinal Cord Stimulation in Chronic Pain
    Maino et al. 
  • Real World Outcomes Using a Novel SCS Device Capable of Engaging Multiple Subperception Mechanisms 
    Metzger et al.  
  • Treatment of Upper Limb and Neck Pain Using Patient-Specific SCS Programming and Neural Targeting Capabilities
    Raoul et al.  
  • Utilization of Fast-Acting Sub-Perception Therapy (FAST) in SCS-Implanted Patients for Mixed Nociceptive and Neuropathic Pain
    Matis et al.  

Eposter

  • Outcomes of a Subperception based Customized Field Shape Used in Treatment of Chronic Pain
    Canos-Verdecho et al. 

  

Paper Posters

  • RAPID: An International, Prospective, Multicenter Study of Radiofrequency Ablation Outcomes in Chronic Pain Patients
    Atallah et al. 

  • Real-World Outcomes Using Pulsed or Thermal Radiofrequency Ablation for Treatment of Chronic Pain in Europe
    Occhigrossi et al. 

  • Treatment of Chronic Knee Pain Using Radiofrequency Ablation: Multicenter, Real-World Observational Study
    Atallah et al. 

  

Paper Posters

  • Biomechanical Impact of Interspinous Spacers on Sagittal Alignment in Patients with Lumbar Spinal Stenosis
    Whang et al.
  • Real-World, Prospective, Multi-Center Study Outcomes Using an Interspinous Spacer for Lumbar Spinal Stenosis
    Sayed et al. 

Eposter

  • Real World Evaluation of Patients Using an Interspinous Spacer for the Treatment of Lumbar Spinal Stenosis
    Esposito et al. 

  

Paper Posters

  • Long-Term Motor Function and Quality of Life Outcomes from a Prospective, International DBS Registry
    Deuschl et al. 

  • Prospective, Multicenter, International Registry of Deep Brain Stimulation for Essential Tremor
    Schuurman et al.

  • Real-World Deep Brain Stimulation Outcomes Using Directional DBS Systems with Multiple Independent Current Control
    Luca et al. 

  • Real-World Outcomes Using Novel Directional DBS Systems for Parkinson's Disease
    Deuschl et al. 

Eposter

  • Visualization Tool for DBS Programming with a Multiple-Source, Constant Current System Reduces Initial Programming Time 
    Aldred et al. 

  

  

Discover WaveWriter Alpha™ SCS System

Designed to Deliver Paresthesia-free Pain Relief in Minutes. It’s About Time.

Use FAST™

Learn about the Vertiflex™ Procedure†: Superion™ Indirect Decompression System

Setting the Standard of Care for Lumbar Spinal Stenosis (LSS)

Learn More

Access Radiofrequency Ablation for Pain Management Education

Our RF Advanced Education Series is Now On Demand

View On Demand Content

Learn More

Visit us at our booth to learn more about our family of neuromodulation solutions.

View Full Program

Superion™ Indirect Decompression System

The WaveWriter Alpha™ SCS System provides safe access to full-body MRI scans when used with specific components and the patient is exposed to the MRI environment under the defined conditions in the ImageReady™ MRI Full Body Guidelines for WaveWriter Alpha and WaveWriter Alpha Prime Spinal Cord Stimulator System

Indications for Use. The Boston Scientific Spinal Cord Stimulator Systems are indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs including unilateral or bilateral pain associated with the following: failed back surgery syndrome, Complex Regional Pain Syndrome (CRPS) Types I and II, intractable low back pain and leg pain.  Associated conditions and etiologies may be: radicular pain syndrome, radiculopathies resulting in pain secondary to failed back syndrome or herniated disc, epidural fibrosis, degenerative disc disease (herniated disc pain refractory to conservative and surgical interventions), arachnoiditis, multiple back surgeries. Contraindications, warnings, precautions, side effects. The SCS Systems are contraindicated for patients who: are unable to operate the SCS System, have failed trial stimulation by failing to receive effective pain relief, are poor surgical risks, or are pregnant. Refer to the Instructions for Use provided with the SCS System or Pain.com for potential adverse effects, warnings, and precautions prior to using this product. Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

www.AlphaSCS.com

Indications for Use. The Superion™ Indirect Decompression System (IDS) is indicated to treat skeletally mature patients suffering from pain, numbness, and/or cramping in the legs (neurogenic intermittent claudication) secondary to a diagnosis of moderate degenerative  lumbar spinal stenosis, with or without Grade 1 spondylolisthesis, having radiographic evidence of thickened ligamentum flavum, narrowed lateral recess, and/or central canal or foraminal narrowing. The Superion™ Interspinous Spacer is indicated for those patients with impaired physical function who experience relief in flexion from symptoms of leg/buttock/groin pain, with or without back pain, who have undergone at least 6 months of non-operative treatment.  The Superion Interspinous Spacer may be implanted at one or two adjacent lumbar levels in patients in whom treatment is indicated at no more than two levels, from L1 to L5. Contraindications, warnings, precautions, side effects. The Superion Indirect Decompression System (IDS) is contraindicated for patients who: have spinal anatomy that prevent implantation of the device or cause the device to be unstable in situ (i.e., degenerative spondylolisthesis greater than grade 1), Cauda equina syndrome, or prior decompression or fusion at the index level. Refer to the Instructions for Use provided on www.vertiflex.com for additional Indications for Use, contraindications information and potential adverse effects, warnings, and precautions prior to using this product. Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

https://www.bostonscientific.com/en-US/products/indirect-decompression-system/superion-indirect-decompression-system/instructions-for-use.html

The Boston Scientific Radiofrequency Generators, associated Radiofrequency Lesion Probes and RF Cannula are indicated for use in procedures to create radiofrequency lesions for the treatment of pain or for lesioning only peripheral nerve tissue for functional neurosurgical procedures. The Boston Scientific RF Injection Electrodes are used for percutaneous nerve blocks with local anesthetic solution for radiofrequency lesioning of peripheral nerve tissue only. The Boston Scientific LCED and Stereotactic TCD Electrodes are indicated for use in radiofrequency (RF) heat lesioning of nervous tissue including the Central Nervous System. Warnings: The Boston Scientific RF devices may cause interference with active devices such as neurostimulators, cardiac pacemakers, and defibrillators. Interference may affect the action of these active devices or may damage them. For appropriate guidance, consult the instructions for use for these active devices. Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

https://www.bostonscientific.com/en-US/products/nerve-radio-frequency-ablation/g4-rf-indications-of-use.html